Terms: = Endocrine gland cancer AND MAF, MGC71685, 4094, ENSG00000178573
58 results:
1. Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer.
Raymant M; Astuti Y; Alvaro-Espinosa L; Green D; Quaranta V; Bellomo G; Glenn M; Chandran-Gorner V; Palmer DH; Halloran C; Ghaneh P; Henderson NC; Morton JP; Valiente M; Mielgo A; Schmid MC
Nat Commun; 2024 Apr; 15(1):3593. PubMed ID: 38678021
[TBL] [Abstract] [Full Text] [Related]
2. High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study.
Huang L; Lv Y; Guan S; Yan H; Han L; Wang Z; Han Q; Dai G; Shi Y
J Transl Med; 2024 Feb; 22(1):184. PubMed ID: 38378604
[TBL] [Abstract] [Full Text] [Related]
3. Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer.
Motobayashi H; Kitahata Y; Okada KI; Miyazawa M; Ueno M; Hayami S; Miyamoto A; Shimizu A; Sato M; Yoshimura T; Nakamura Y; Takemoto N; Nakai T; Hyo T; Matsumoto K; Yamaue H; Kawai M
J Cancer Res Clin Oncol; 2024 Jan; 150(2):35. PubMed ID: 38277079
[TBL] [Abstract] [Full Text] [Related]
4. Genetic determinants of IgG antibody response to COVID-19 vaccination.
Bian S; Guo X; Yang X; Wei Y; Yang Z; Cheng S; Yan J; Chen Y; Chen GB; Du X; Francis SS; Shu Y; Liu S
Am J Hum Genet; 2024 Jan; 111(1):181-199. PubMed ID: 38181733
[TBL] [Abstract] [Full Text] [Related]
5. Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians.
Piccardi M; Gentiluomo M; Bertoncini S; Pezzilli R; Erőss B; Bunduc S; Uzunoglu FG; Talar-Wojnarowska R; Vanagas T; Sperti C; Oliverius M; Aoki MN; Ermini S; Hussein T; Boggi U; Jamroziak K; Maiello E; Morelli L; Vodickova L; Di Franco G; Landi S; Szentesi A; Lovecek M; Puzzono M; Tavano F; van Laarhoven HWM; Zerbi A; Mohelnikova-Duchonova B; Stocker H; Costello E; Capurso G; Ginocchi L; Lawlor RT; Vanella G; Bazzocchi F; Izbicki JR; Latiano A; Bueno-de-Mesquita B; Ponz de Leon Pisani R; Schöttker B; Soucek P; Hegyi P; Gazouli M; Hackert T; Kupcinskas J; Poskiene L; Tacelli M; Roth S; Carrara S; Perri F; Hlavac V; Theodoropoulos GE; Busch OR; Mambrini A; van Eijck CHJ; Arcidiacono P; Scarpa A; Pasquali C; Basso D; Lucchesi M; Milanetto AC; Neoptolemos JP; Cavestro GM; Janciauskas D; Chen X; Chammas R; Goetz M; Brenner H; Archibugi L; Dannemann M; Canzian F; Tofanelli S; Campa D
Biol Res; 2023 Aug; 56(1):46. PubMed ID: 37574541
[TBL] [Abstract] [Full Text] [Related]
6. Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas.
Leick KM; Tomanek-Chalkley A; Coleman KL; Chan CHF
Ann Surg Oncol; 2023 Oct; 30(11):6652-6660. PubMed ID: 37303025
[TBL] [Abstract] [Full Text] [Related]
7. Insulinomatosis: new aspects.
Christ E; Iacovazzo D; Korbonits M; Perren A
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36952647
[TBL] [Abstract] [Full Text] [Related]
8. Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background.
Eng ZH; Abdullah MI; Ng KL; Abdul Aziz A; Arba'ie NH; Mat Rashid N; Mat Junit S
Front Endocrinol (Lausanne); 2022; 13():1039494. PubMed ID: 36686473
[TBL] [Abstract] [Full Text] [Related]
9. A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma.
van Eijck CWF; de Koning W; van der Sijde F; Moskie M; Groot Koerkamp B; Homs MYV; van der Burg SH; van Eijck CHJ; Mustafa DAM
Eur J Cancer; 2023 Mar; 181():119-134. PubMed ID: 36652890
[TBL] [Abstract] [Full Text] [Related]
10. Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience.
Gerratana L; Movarek M; Wehbe F; Katam N; Mahalingam D; Donahue J; Shah A; Chae YK; Mulcahy M; Tsarwhas D; Villaflor V; Kalyan A; Hussein M; Patel J; Chandra S; Platanias LC; Gradishar W; Cristofanilli M; Behdad A
JCO Precis Oncol; 2022 Jun; 6():e2100289. PubMed ID: 35772051
[TBL] [Abstract] [Full Text] [Related]
11. KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence.
Amintas S; Fernandez B; Chauvet A; Chiche L; Laurent C; Belleannée G; Marty M; Buscail E; Dabernat S
Sci Rep; 2022 Feb; 12(1):2976. PubMed ID: 35194118
[TBL] [Abstract] [Full Text] [Related]
12. Genetic variation in progesterone receptor gene and ovarian cancer risk: A case control study.
Kanabekova P; Al-Awadi AM; Bauyrzhanova Z; Tahtouh T; Sarray S; Almawi WY
Gene; 2022 Apr; 820():146288. PubMed ID: 35143942
[TBL] [Abstract] [Full Text] [Related]
13. Whole-exome sequencing reveals rare genetic variations in ovarian granulosa cell tumor.
Kim S; Kim S; Mun S; Kwak Y; Suh KS; Choi SY; Han K
Bosn J Basic Med Sci; 2022 Jun; 22(3):403-411. PubMed ID: 35038288
[TBL] [Abstract] [Full Text] [Related]
14. Targeted Transcriptome and
Lundy J; Gao H; Berry W; Masoumi-Moghoddam S; Jenkins BJ; Croagh D
Clin Cancer Res; 2021 Nov; 27(21):5900-5911. PubMed ID: 34400416
[TBL] [Abstract] [Full Text] [Related]
15. Co-Occurrence of Familial Non-Medullary Thyroid cancer (FNMTC) and Hereditary Non-Polyposis Colorectal cancer (HNPCC) Associated Tumors-A Cohort Study.
Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
[TBL] [Abstract] [Full Text] [Related]
16. Assessing Genetic Variants in Matched Biocompartments From Patients With Serous Ovarian cancer.
Sanders BE; Ku L; Walker P; Bitler BG
Technol Cancer Res Treat; 2021; 20():15330338211027917. PubMed ID: 34169762
[TBL] [Abstract] [Full Text] [Related]
17. Next Generation Sequencing-Based Germline Panel Testing for Breast and Ovarian cancers in Pakistan.
Tariq H; Gul A; Khadim T; Ud-Din H; Tipu HN; Asif M; Ahmed R
Asian Pac J Cancer Prev; 2021 Mar; 22(3):719-724. PubMed ID: 33773534
[TBL] [Abstract] [Full Text] [Related]
18. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J
PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613
[TBL] [Abstract] [Full Text] [Related]
19. Ethnicity as modifier of risk for Vitamin D receptors polymorphisms: Comprehensive meta-analysis of all cancer sites.
Gnagnarella P; Raimondi S; Aristarco V; Johansson H; Bellerba F; Corso F; De Angelis SP; Belloni P; Caini S; Gandini S
Crit Rev Oncol Hematol; 2021 Feb; 158():103202. PubMed ID: 33387627
[TBL] [Abstract] [Full Text] [Related]
20. The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
Hu Y; Zhang X; Wang O; Bi Y; Xing X; Cui M; Wang M; Tao W; Liao Q; Zhao Y
Int J Cancer; 2020 Nov; 147(9):2446-2457. PubMed ID: 32574388
[TBL] [Abstract] [Full Text] [Related]
[Next]
